CLEARSIDE BIOMEDICAL, INC. Shares of Common Stock (par value $0.001 per share) Controlled Equity OfferingSM Sales AgreementSales Agreement • May 12th, 2023 • Clearside Biomedical, Inc. • Pharmaceutical preparations • New York
Contract Type FiledMay 12th, 2023 Company Industry JurisdictionClearside Biomedical, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Cantor Fitzgerald & Co. (the “Agent”), as follows: